Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PHAR | Amsterdam | EUR | Real-time | |
PHARMa | BATS Europe | EUR | Delayed | |
PHAR | NASDAQ | USD | Real-time | |
PHGN | Frankfurt | EUR | Delayed |
Period Ending: | 2023 31/12 |
2023 30/09 |
2023 30/06 |
2023 31/03 |
||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 81.2 | 66.7 | 54.9 | 42.54 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Cost of Revenue, Total | 7.1 | 8.3 | 5.72 | 4.08 | ||||||||||||||||||||||||||||||
Gross Profit | 74.1 | 58.4 | 49.17 | 38.47 | ||||||||||||||||||||||||||||||
Total Operating Expenses | 80.1 | 64.8 | 70.68 | 56.2 | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Operating Income | 1.1 | 1.9 | -15.78 | -13.66 | ||||||||||||||||||||||||||||||
Interest Income (Expense), Net Non-Operating | - | - | - | - | ||||||||||||||||||||||||||||||
Gain (Loss) on Sale of Assets | - | - | 21.08 | - | ||||||||||||||||||||||||||||||
Other, Net | 3.1 | -1.4 | -40.25 | 3.01 | ||||||||||||||||||||||||||||||
Net Income Before Taxes | -2 | 3.3 | 3.39 | -16.67 | ||||||||||||||||||||||||||||||
Provision for Income Taxes | 0.7 | -0.2 | 2.07 | -4.47 | ||||||||||||||||||||||||||||||
Net Income After Taxes | -2.7 | 3.5 | 1.32 | -12.21 | ||||||||||||||||||||||||||||||
Minority Interest | - | - | - | - | ||||||||||||||||||||||||||||||
Equity In Affiliates | - | - | - | - | ||||||||||||||||||||||||||||||
U.S GAAP Adjustment | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income Before Extraordinary Items | -2.7 | 3.5 | 1.32 | -12.21 | ||||||||||||||||||||||||||||||
Total Extraordinary Items | - | - | - | - | ||||||||||||||||||||||||||||||
Net Income | -2.7 | 3.5 | 1.32 | -12.21 | ||||||||||||||||||||||||||||||
Total Adjustments to Net Income | - | - | - | - | ||||||||||||||||||||||||||||||
Income Available to Common Excluding Extraordinary Items | -2.7 | 3.5 | 1.32 | -12.21 | ||||||||||||||||||||||||||||||
Dilution Adjustment | - | - | 0.285 | - | ||||||||||||||||||||||||||||||
Diluted Net Income | -2.7 | 3.5 | 1.03 | -12.21 | ||||||||||||||||||||||||||||||
Diluted Weighted Average Shares | 675 | 700 | 672.01 | 642.53 | ||||||||||||||||||||||||||||||
Diluted EPS Excluding Extraordinary Items | -0.004 | 0.005 | 0.002 | -0.019 | ||||||||||||||||||||||||||||||
DPS - Common Stock Primary Issue | - | - | - | - | ||||||||||||||||||||||||||||||
Diluted Normalized EPS | -0.002 | 0.003 | -0.016 | -0.016 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review